Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis

BACKGROUND: Cilostazol has been reported to alleviate the metabolic syndrome induced by increased intracellular adenosine 3’,5’-cyclic monophosphate (cAMP) levels, which is also associated with osteoclast (OC) differentiation. We hypothesized that bone loss might be attenuated via an action on OC by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Ke, Safder, Ali Muhammad, Sul, Ok-Joo, Suh, Jae-Hee, Joe, Yeonsoo, Chung, Hun-Taeg, Choi, Hye-Seon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436362/
https://www.ncbi.nlm.nih.gov/pubmed/25992691
http://dx.doi.org/10.1371/journal.pone.0124869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436362/
https://www.ncbi.nlm.nih.gov/pubmed/25992691
http://dx.doi.org/10.1371/journal.pone.0124869

Ejemplares similares